Skip to main content

Tilray Brands, Inc.

TLRY
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001731348

No open-market purchases or sales by Tilray Brands, Inc. insiders were filed in the last 90 days; 240 institutions reported holding it in 13F filings for Q2 2026, worth $62.7M in total; no superinvestor holds it.

Holders of 5% or more of TLRY

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Tilray Brands, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Tilray Brands, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

8 Schedule 13D and 13G filings on Tilray Brands, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on TLRY
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 13, 2023Hudson Bay Capital Management LP13G/AOld format–––SEC
Feb 10, 2023Hudson Bay Capital Management LP13GOld format–New–SEC
May 25, 2021Kennedy Brendan13D/AOld format–––SEC
Feb 16, 2021ETF Managers Group, LLC13G/AOld format–––SEC
Feb 16, 2021Groh Christian13D/AOld format–––SEC
Feb 16, 2021Blue Michael G.13D/AOld format–––SEC
Feb 16, 2021Kennedy Brendan13D/AOld format–––SEC
Feb 16, 2021CVI Investments, Inc.13G/AOld format–––SEC

Form 144: proposed insider sales

1 notice from officers, directors and other affiliates planning to sell Tilray Brands, Inc. shares, newest first.

Form 144 notices for TLRY
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Apr 21, 20264:15 PM ETHopkinson David G.Director33.6K$232.9KApr 21, 2026Stifel Nicolaus & Company IncSEC